科研之友ScholarMate
免费注册
首页 论文 论文详情
赞 收藏 引用

A randomized open-label study of bortezomib, melphalan, and prednisone (VMP) versus daratumumab (DARA) plus VMP in patients with previously untreated multiple myeloma (MM) who are ineligible for high-dose therapy: 54767414MMY3007 (Alcyone).

作者：Mateos Mara Victoria; Cavo Michele; Jakubowiak Andrzej J; Carson Robin L; Qi Ming; Bandekar Rajesh; Crist Wendy; Ahmadi Tahamtan; San Miguel Jesus F
来源：Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2015-05-29 to 2015-06-02.
  • 出版日期2015-5-20
收藏 分享 被引(3) 浏览
更新时间：2018-01-17 18:50